SFM
LOXO

Sphera Funds Management’s Loxo Oncology, Inc LOXO Stock Holding History

Sphera Funds Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-45,000
Closed -$1.28M – 136
2015
Q4 		$1.28M Buy
+45,000
New +$1.21M 0.19% 104

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Sphera Funds Management's LOXO Position: Q1 2016 in Review

Sphera Funds Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2016, closing a stake of 45,000 shares — an estimated $1.28M sold.

Sphera Funds Management first reported a position in LOXO in Q4 2015 and held it in 1 quarter. The position peaked at $1.28M in Q4 2015. 67 funds tracked by Wall St. Rank hold LOXO as of Q1 2016.

  • Sphera Funds Management reported no remaining Loxo Oncology, Inc position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 45,000 Loxo Oncology, Inc shares in Q1 2016, an estimated $1.28M.
  • Sphera Funds Management first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 1 quarter.
  • Sphera Funds Management's Loxo Oncology, Inc position peaked at $1.28M in Q4 2015.
  • 67 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.